Although we still observed the presence of Tregs in these tumors, the ratio of CD8+ T cells to Tregs was significantly increased in the tumor infiltrates from ESC/STO-GM vaccinated mice (n = 3/group; t test, p<0.05; relative to control group; Fig. 5B, C). This evidence concerns the gene CD8A and neoplasm.